Si-Bone Inc
SI-BONE, Inc., a medical device company, focuses on solving musculoskeletal disorders of the sacropelvic anatomy in the United States and internationally. The company offers proprietary minimally invasive surgical implant systems to address sacroiliac joint dysfunction and degeneration, adult deformity and degeneration, and pelvic trauma, as well as implantable bone products. It also provides iFu… Read more
Si-Bone Inc (SIBN) - Total Assets
Latest total assets as of September 2025: $234.27 Million USD
Based on the latest financial reports, Si-Bone Inc (SIBN) holds total assets worth $234.27 Million USD as of September 2025.
Total assets represent everything the company owns and controls, combining both current assets—like cash and cash equivalents, accounts receivable, and inventories—and non-current assets such as property, plant, equipment (PP&E), intangible assets, and long-term investments.
Si-Bone Inc - Total Assets Trend (2013–2024)
This chart illustrates how Si-Bone Inc’s total assets have evolved over time, based on quarterly financial data. Explore and compare other companies by total assets.
Si-Bone Inc - Asset Composition Analysis
Current Asset Composition (December 2024)
Si-Bone Inc's total assets of $234.27 Million consist of 90.2% current assets and 9.8% non-current assets.
| Asset Category | Amount (USD) | % of Total Assets |
|---|---|---|
| Cash & Equivalents | $0.00 | 15.2% |
| Accounts Receivable | $27.46 Million | 11.9% |
| Inventory | $27.07 Million | 11.8% |
| Property, Plant & Equipment | $0.00 | 0.0% |
| Intangible Assets | $0.00 | 0.0% |
| Goodwill | $0.00 | 0.0% |
Asset Composition Trend (2013–2024)
This chart illustrates how Si-Bone Inc's asset composition has evolved over time. Understanding changes in asset allocation can provide insights into the company's strategic shifts, capital allocation priorities, and business focus evolution.
Key Asset Composition Facts
- Current vs. Non-Current Assets: Si-Bone Inc's current assets represent 90.2% of total assets in 2024, a decrease from 91.4% in 2013.
- Cash Position: Cash and equivalents constituted 15.2% of total assets in 2024, down from 47.3% in 2013.
- Tangible vs. Intangible: Intangible assets (including goodwill) make up 0.0% of total assets, unchanged from 0.0% in 2013.
- Asset Diversification: The largest asset category is accounts receivable at 11.9% of total assets.
Si-Bone Inc Competitors by Total Assets
Key competitors of Si-Bone Inc based on total assets are shown below.
| Company | Country | Total Assets |
|---|---|---|
|
Shanghai Kehua Bio-Engineering Co Ltd
SHE:002022
|
China | CN¥5.17 Billion |
|
Jiangsu Yuyue Medical Equipment & Supply Co Ltd
SHE:002223
|
China | CN¥16.67 Billion |
|
Double Medical Technology Inc
SHE:002901
|
China | CN¥4.55 Billion |
|
Wuhan Easy Diagnosis Biomedicine Co Ltd Class A
SHE:002932
|
China | CN¥6.10 Billion |
|
Shinhung
KO:004080
|
Korea | ₩153.50 Billion |
|
UMediC Group Berhad
KLSE:0256
|
Malaysia | RM94.93 Million |
|
Osang Healthcare Co.,Ltd
KQ:036220
|
Korea | ₩287.70 Billion |
|
HansBiomed Corporation
KQ:042520
|
Korea | ₩126.41 Billion |
Si-Bone Inc - Asset Efficiency Metrics
Asset efficiency metrics measure how effectively a company uses its assets to generate revenue and profits. These indicators help investors evaluate management's ability to deploy capital efficiently.
Asset Turnover Ratio
Measures how efficiently a company uses its assets to generate sales
Strong asset utilization - Si-Bone Inc generates 0.73x its asset value in annual revenue.
Return on Assets (ROA)
Measures how efficiently a company uses its assets to generate profits
Negative ROA - Si-Bone Inc is currently not profitable relative to its asset base.
Si-Bone Inc - Liquidity and Working Capital Analysis
Liquidity ratios measure a company's ability to pay off its short-term debts as they come due, using the company's current or quick assets. Working capital represents the operational liquidity available.
Key Liquidity Metrics
| Metric | Current | 1 Year Ago | 5 Years Ago |
|---|---|---|---|
| Current Ratio | 7.97 | 8.25 | 16.20 |
| Quick Ratio | 6.62 | 7.22 | 15.78 |
| Cash Ratio | 0.00 | 0.00 | 0.00 |
| Working Capital | $184.34 Million | $ 179.01 Million | $ 204.77 Million |
Si-Bone Inc - Advanced Valuation Insights
This section examines the relationship between Si-Bone Inc's asset base and its market valuation, helping to identify whether the company's assets are efficiently translated into market value.
Key Valuation Metrics
| Current Price-to-Book Ratio | 3.78 |
| Latest Market Cap to Assets Ratio | 2.20 |
| Asset Growth Rate (YoY) | 0.0% |
| Total Assets | $230.44 Million |
| Market Capitalization | $507.40 Million USD |
Valuation Analysis
Premium Asset Valuation: The market values Si-Bone Inc's assets at a significant premium ( 2.20x), suggesting investors see substantial growth potential or unique competitive advantages.
Slight Asset Contraction: Si-Bone Inc's assets decreased by 0.0% over the past year, which may reflect streamlining or optimization of resources.
Annual Total Assets for Si-Bone Inc (2013–2024)
The table below shows the annual total assets of Si-Bone Inc from 2013 to 2024.
| Year | Total Assets | Change |
|---|---|---|
| 2024-12-31 | $230.44 Million | +0.01% |
| 2023-12-31 | $230.43 Million | +46.25% |
| 2022-12-31 | $157.55 Million | -17.30% |
| 2021-12-31 | $190.51 Million | -14.63% |
| 2020-12-31 | $223.14 Million | +90.70% |
| 2019-12-31 | $117.01 Million | -15.53% |
| 2018-12-31 | $138.52 Million | +286.56% |
| 2017-12-31 | $35.83 Million | -9.13% |
| 2016-12-31 | $39.44 Million | +9.38% |
| 2015-12-31 | $36.05 Million | +24.39% |
| 2014-12-31 | $28.98 Million | +60.90% |
| 2013-12-31 | $18.01 Million | -- |